Hazel M Aker insider trades: Oncternal Therapeutics (ONCT) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Hazel reports to the SEC
Open-market buys and sales
6 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jul 21, 2020 | ONCT | ↑ Buy | 41,972 | $2.38 | $100K | By family trust. | Jul 23, 2020 (2d) |
| Dec 16, 2013 | CADX | ↓ Sell | 13,014 | $8.76 | $114K | Direct | Dec 18, 2013 (2d) |
| Nov 15, 2013 | CADX | ↓ Sell | 52,056 | $7.41 | $385K | Direct | Nov 18, 2013 (3d) |
| Jul 22, 2013 | CADX | ↓ Sell | 6,507 | $7.81 | $51K | Direct | Jul 23, 2013 (1d) |
| Jul 15, 2013 | CADX | ↓ Sell | 6,508 | $7.34 | $48K | Direct | Jul 17, 2013 (2d) |
| Nov 21, 2011 | CADX | ↓ Sell | 10,000 | $4.16 | $42K | Direct | Nov 22, 2011 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Hazel M Aker's insider trades
Hazel M Aker is Legal Counsel at Oncternal Therapeutics (ONCT). Since Nov 21, 2011, Hazel has reported 1 open-market purchase worth $100K and 5 sales worth $640K on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (17 filings), option exercises (5 filings), other transactions (1 filing), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ONCT insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.